Dr. Karakunnel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
8901 Wisconsin ave
Bldg 19 Rm. 3644
Bethesda, MD 20889Phone+1 301-641-6063- Is this information wrong?
Education & Training
- University of MarylandMS, Pharmacology, 2005 - 2008
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2008
- University of MarylandFellowship, Hematology and Medical Oncology, 2005 - 2006
- Clinical Center at the National Institutes of HealthFellowship, Hospice and Palliative Medicine, 2005
- Atlantic Health System/Overlook Medical CenterResidency, Internal Medicine, 2000 - 2003
- Rajah Muthiah Medical CollegeClass of 2000
Certifications & Licensure
- VA State Medical License 2005 - 2020
- CA State Medical License 2017 - 2019
- WI State Medical License 2012 - 2017
- DC State Medical License 2015 - 2016
- MD State Medical License 2003 - 2016
- KY State Medical License 2013 - 2014
- ME State Medical License 2012 - 2014
- Join now to see all
Clinical Trials
- A Phase 1b Study of MEDI4736 in Combination With Tremelimumab in Subjects With Advanced Non-small Cell Lung Cancer Start of enrollment: 2013 Oct 25
- A Phase 1 Multicenter Open-label Study to Evaluate the Safety Tolerability and PK of MEDI0680 (AMP-514) in Subjects With Advanced Malignancies Start of enrollment: 2013 Dec 19
- Phase 1 Study to Evaluate MEDI4736 in Subjects With Myelodysplastic Syndrome Start of enrollment: 2014 May 20
- Join now to see all
Publications & Presentations
PubMed
- 86 citationsSotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial.Lacey J Padrón, Deena M Maurer, Mark H O'Hara, Eileen M O'Reilly, Robert A Wolff, Zev A Wainberg, Andrew H Ko, George Fisher, Osama Rahma, Jaclyn P Lyman, Christopher ...> ;Nature Medicine. 2022 Jun 1
- 15 citationsIpilimumab alone or in combination with nivolumab in patients with advanced melanoma who have progressed or relapsed on PD-1 blockade: clinical outcomes and translatio...Friedman, C., Spencer, C., Cabanski, C., Panageas, K., Wells, D., Ribas, A., Tawbi, H., Tsai, K., Postow, M., Shoushtari, A., Chapman, P., Karakunnel, J., Bucktrout, S...> ;Journal for Immunotherapy of Cancer. 2022 Jan 1
- 124 citationsCD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an ope...Mark H. O'Hara, Eileen M. O'Reilly, Gauri R. Varadhachary, Robert A. Wolff, Zev A. Wainberg, Andrew H. Ko, George A. Fisher, Osama E. Rahma, Jaclyn P. Lyman, Christoph...> ;The Lancet. Oncology. 2021 Jan 1
- Join now to see all
Press Mentions
- Innate Pharma Presents Preliminary Data from TELLOMAK Trial Showing Clinical Response for Lacutamab in Mycosis FungoidesJune 22nd, 2021
- Innate Pharma Announces Conference Call and Webcast for 2021 First Quarter Business UpdateMay 3rd, 2021
- Innate Pharma Announces Conference Call and Webcast for Full Year 2020 Financial ResultsMarch 15th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: